Orion OYJ EBITDA 2017-2025 | ORINY

Orion OYJ annual and quarterly EBITDA history from 2017 to 2025. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.

Orion OYJ EBITDA for the quarter ending September 30, 2025 was $0.141B, a 36.32% decline year-over-year.
Orion OYJ EBITDA for the twelve months ending September 30, 2025 was $0.439B, a 3.19% decline year-over-year.
Orion OYJ 2024 annual EBITDA was $0.551B, a 55.96% increase from 2023.
Orion OYJ 2023 annual EBITDA was $0.353B, a 31.16% decline from 2022.
Orion OYJ 2022 annual EBITDA was $0.513B, a 50.08% increase from 2021.

Orion OYJ Annual EBITDA (Millions of US $)
2024	$551
2023	$353
2022	$513
2021	$342
2020	$384
2019	$346
2018	$348
2017	$379
2016	$393

Orion OYJ Quarterly EBITDA (Millions of US $)
2025-09-30	$141
2025-06-30	$119
2025-03-31	$82
2024-12-31	$97
2024-09-30	$222
2024-06-30	$71
2024-03-31	$61
2023-12-31	$100
2023-09-30	$87
2023-06-30	$51
2023-03-31	$59
2022-12-31	$49
2022-09-30	$247
2022-06-30	$87
2022-03-31	$80
2021-12-31	$44
2021-09-30	$68
2021-06-30	$86
2021-03-31	$90
2020-12-31	$45
2020-09-30	$76
2020-06-30	$106
2020-03-31	$93
2019-12-31	$61
2019-09-30	$101
2019-06-30	$59
2019-03-31	$62
2018-12-31	$78
2018-09-30	$52
2018-06-30	$83
2018-03-31	$86
2017-12-31	$88
2017-09-30	$66
2017-06-30	$79
2017-03-31	$98
2016-12-31	$302

Sector	Industry	Market Cap	Revenue
Medical	Medical - Drug Manufacturing	$10.204B	$1.669B
Orion Oyj is a pharmaceutical company. It develops, manufactures and markets human and veterinary pharmaceuticals, active pharmaceutical ingredients and diagnostic tests. The company's core therapy consists of central nervous system disorders, oncology and respiratory. Its product pipeline includes inhaled Easyhaler(R) pulmonary drugs. Orion Oyj is headquartered in Espoo, Finland.

Stock Name	Country	Market Cap	PE Ratio
Chugai Pharmaceutical (CHGCY)	Japan	$88.134B	33.47
Zoetis (ZTS)	United States	$55.457B	19.85
Takeda Pharmaceutical (TAK)	Japan	$52.407B	10.69
Daiichi Sankyo, - (DSNKY)	Japan	$40.558B	20.20
BeOne Medicines - (ONC)	Switzerland	$38.026B	201.60
Sandoz Group AG (SDZNY)	Switzerland	$33.757B	0.00
United Therapeutics (UTHR)	United States	$20.483B	18.03
Merck (MKKGY)	Germany	$19.238B	11.86
Shionogi (SGIOY)	Japan	$15.687B	14.41
Summit Therapeutics (SMMT)	United States	$13.611B	0.00
Neurocrine Biosciences (NBIX)	United States	$13.493B	32.38
Ionis Pharmaceuticals (IONS)	United States	$12.775B	0.00
IPSEN (IPSEY)	France	$12.596B	0.00
Madrigal Pharmaceuticals (MDGL)	United States	$11.474B	0.00
Eisai (ESAIY)		$8.539B	0.00
Ono Pharmaceutical (OPHLF)	Japan	$6.576B	20.00
Grifols, S.A (GRFS)	Spain	$6.353B	0.00
Stevanato Group S.p.A (STVN)	Italy	$6.196B	34.68
Crinetics Pharmaceuticals (CRNX)	United States	$5.259B	0.00
Hikma Pharmaceuticals Plc (HKMPF)	United Kingdom	$4.613B	0.00
Indivior (INDV)	United States	$4.204B	17.16
AMNEAL PHARMACEUTICALS, INC (AMRX)	United States	$4.165B	19.78
Corcept Therapeutics (CORT)	United States	$3.896B	42.09
NewAmsterdam Pharma (NAMS)	Netherlands	$3.619B	0.00
Centessa Pharmaceuticals (CNTA)	United Kingdom	$2.969B	0.00
Catalyst Pharmaceuticals (CPRX)	United States	$2.848B	9.09
Hypermarcas (HYPMY)	Brazil	$2.717B	18.65
Dyne Therapeutics (DYN)	United States	$2.492B	0.00
Ocular Therapeutix (OCUL)	United States	$2.358B	0.00
Soleno Therapeutics (SLNO)	United States	$2.281B	0.00
Avadel Pharmaceuticals (AVDL)	Ireland	$2.100B	0.00
Aurinia Pharmaceuticals Inc (AUPH)	Canada	$2.008B	23.80
Guardian Pharmacy Services (GRDN)	United States	$1.908B	36.74
Harrow (HROW)	United States	$1.784B	109.46
Ardelyx (ARDX)	United States	$1.674B	0.00
Oruka Therapeutics (ORKA)	United States	$1.549B	0.00
Enliven Therapeutics (ELVN)	United States	$1.546B	0.00
Amylyx Pharmaceuticals (AMLX)	United States	$1.545B	0.00
Collegium Pharmaceutical (COLL)	United States	$1.472B	7.29
BioCryst Pharmaceuticals (BCRX)	United States	$1.429B	84.75
Relay Therapeutics (RLAY)	United States	$1.399B	0.00
Evotec AG (EVO)	Germany	$1.314B	0.00
Xeris Biopharma Holdings (XERS)	United States	$1.258B	0.00
Savara (SVRA)	United States	$1.221B	0.00
ARS Pharmaceuticals (SPRY)	United States	$1.165B	0.00
Theravance Biopharma (TBPH)	United States	$1.044B	43.85
Xencor (XNCR)	United States	$1.032B	0.00
Cronos Group (CRON)	Canada	$1.006B	0.00
Esperion Therapeutics (ESPR)	United States	$0.772B	0.00
KalVista Pharmaceuticals (KALV)	United States	$0.770B	0.00
Ironwood Pharmaceuticals (IRWD)	United States	$0.739B	17.46
Nektar Therapeutics (NKTR)	United States	$0.734B	0.00
Rigel Pharmaceuticals (RIGL)	United States	$0.710B	6.34
ProKidney (PROK)	United States	$0.686B	0.00
Bioventus (BVS)	United States	$0.641B	13.12
Lexeo Therapeutics (LXEO)	United States	$0.563B	0.00
Zevra Therapeutics (ZVRA)	United States	$0.516B	0.00
Elite Pharmaceuticals (ELTP)	United States	$0.513B	0.00
4D Molecular Therapeutics (FDMT)	United States	$0.501B	0.00
Lyell Immunopharma (LYEL)	United States	$0.498B	0.00
Organogenesis (ORGO)	United States	$0.491B	0.00
Siga Technologies (SIGA)	United States	$0.481B	6.59
Altimmune (ALT)	United States	$0.436B	0.00
Aquestive Therapeutics (AQST)	United States	$0.429B	0.00
Nature's Sunshine Products (NATR)	United States	$0.389B	23.18
USANA Health Sciences (USNA)	United States	$0.374B	10.45
Akebia Therapeutics (AKBA)	United States	$0.366B	0.00
Avalo Therapeutics (AVTX)	United States	$0.300B	0.00
Achieve Life Sciences (ACHV)	Canada	$0.299B	0.00
Aclaris Therapeutics (ACRS)	United States	$0.297B	0.00
Larimar Therapeutics (LRMR)	United States	$0.282B	0.00
Relmada Therapeutics (RLMD)	United States	$0.282B	0.00
Silence Therapeutics (SLN)	United Kingdom	$0.277B	0.00
Profound Medical (PROF)	Canada	$0.277B	0.00
Fractyl Health (GUTS)	United States	$0.275B	0.00
OmniAb (OABI)	United States	$0.275B	0.00
Heron Therapeutics (HRTX)	United States	$0.273B	0.00
Aldeyra Therapeutics (ALDX)	United States	$0.255B	0.00
Protara Therapeutics (TARA)	United States	$0.255B	0.00
Enlivex Therapeutics (ENLV)	Israel	$0.229B	0.00
Journey Medical (DERM)	United States	$0.213B	0.00
Tonix Pharmaceuticals Holding (TNXP)	United States	$0.206B	0.00
Galectin Therapeutics (GALT)	United States	$0.193B	0.00
MediWound (MDWD)	Israel	$0.189B	0.00
Minerva Neurosciences (NERV)	United States	$0.187B	0.00
Innate Pharma SA (IPHYF)	France	$0.181B	0.00
Century Therapeutics (IPSC)	United States	$0.177B	0.00
Surrozen (SRZN)	United States	$0.171B	0.00
AleAnna (ANNA)	United States	$0.167B	0.00
Procaps Group, S.A (PROCF)	Luxembourg	$0.161B	0.00
Corbus Pharmaceuticals Holdings (CRBP)	United States	$0.145B	0.00
Context Therapeutics (CNTX)	United States	$0.144B	0.00
Prelude Therapeutics (PRLD)	United States	$0.142B	0.00
Unicycive Therapeutics (UNCY)	United States	$0.142B	0.00
Incannex Healthcare (IXHL)	Australia	$0.135B	0.00
VAXART, INC (VXRT)	United States	$0.132B	0.00
Karyopharm Therapeutics (KPTI)	United States	$0.132B	0.00
Inhibikase Therapeutics (IKT)	United States	$0.128B	0.00
Verrica Pharmaceuticals (VRCA)	United States	$0.127B	0.00
Pyxis Oncology (PYXS)	United States	$0.124B	0.00
Avita Medical (RCEL)	United States	$0.107B	0.00
Cassava Sciences (SAVA)	United States	$0.104B	0.00
Champions Oncology (CSBR)	United States	$0.100B	42.24
Cardiol Therapeutics (CRDL)	Canada	$0.097B	0.00
Vivani Medical (VANI)	United States	$0.093B	0.00
Korro Bio (KRRO)	United States	$0.085B	0.00
Gain Therapeutics (GANX)	United States	$0.085B	0.00
Cumberland Pharmaceuticals (CPIX)	United States	$0.073B	61.00
PolyPid (PYPD)	Israel	$0.069B	0.00
Dominari Holdings (DOMH)	United States	$0.069B	0.00
Rafael Holdings (RFL)	United States	$0.066B	0.00
Arch Biopartners (ACHFF)	Canada	$0.066B	0.00
Assertio Holdings (ASRT)	United States	$0.066B	0.00
Metagenomi (MGX)	United States	$0.065B	0.00
NRx Pharmaceuticals (NRXP)	United States	$0.064B	0.00
Lipocine (LPCN)	United States	$0.061B	0.00
PMV Pharmaceuticals (PMVP)	United States	$0.061B	0.00
Acrivon Therapeutics (ACRV)	United States	$0.058B	0.00
Lite Strategy (LITS)	United States	$0.057B	0.00
ElectroCore (ECOR)	United States	$0.052B	0.00
Nutriband (NTRB)	United States	$0.052B	0.00
Talphera (TLPH)	United States	$0.048B	0.00
Telomir Pharmaceuticals (TELO)	United States	$0.046B	0.00
Plus Therapeutics (PSTV)	United States	$0.040B	0.00
Reviva Pharmaceuticals Holdings (RVPH)	United States	$0.040B	0.00
FibroGen (FGEN)	United States	$0.039B	0.00
Kyntra Bio Inc (KYNB)	United States	$0.038B	0.00
Wellgistics Health (WGRX)	United States	$0.037B	0.00
Mural Oncology (MURA)	Ireland	$0.035B	0.00
MARKER THERAPEUTICS, INC (MRKR)	United States	$0.030B	0.00
Natural Alternatives (NAII)	United States	$0.029B	0.00
Jupiter Neurosciences (JUNS)	United States	$0.028B	0.00
SCYNEXIS (SCYX)	United States	$0.027B	0.00
TherapeuticsMD (TXMD)	United States	$0.025B	0.00
Klotho Neurosciences (KLTO)	United States	$0.022B	0.00
Scienture Holdings (SCNX)	United States	$0.021B	0.00
Inotiv (NOTV)	United States	$0.021B	0.00
Liminatus Pharma (LIMN)	United States	$0.020B	0.00
VYNE Therapeutics (VYNE)	United States	$0.019B	0.00
Vivos Therapeutics (VVOS)	United States	$0.019B	0.00
Citius Pharmaceuticals (CTXR)	United States	$0.018B	0.00
Iterum Therapeutics (ITRM)	Ireland	$0.017B	0.00
Vyome Holdings (HIND)	United States	$0.017B	0.00
Cosmos Health (COSM)	United States	$0.017B	0.00
Mannatech (MTEX)	United States	$0.014B	0.00
Traws Pharma (TRAW)	United States	$0.014B	0.02
Tempest Therapeutics (TPST)	United States	$0.013B	0.00
CASI Pharmaceuticals (CASI)	China	$0.013B	0.00
BioLineRx (BLRX)	Israel	$0.012B	0.00
Phio Pharmaceuticals (PHIO)	United States	$0.012B	0.00
China SXT Pharmaceuticals (SXTC)	China	$0.011B	0.00
Mangoceuticals (MGRX)	United States	$0.011B	0.00
Curanex Pharmaceuticals Inc (CURX)	United States	$0.010B	0.00
Addex Therapeutics (ADXN)	Switzerland	$0.010B	0.00
Ernexa Therapeutics (ERNA)	United States	$0.010B	0.00
Quoin Pharmaceuticals (QNRX)	United States	$0.009B	0.00
Nuvilex (PMCB)	United States	$0.009B	0.00
Ainos (AIMD)	United States	$0.009B	0.00
BioVie (BIVI)	United States	$0.009B	0.00
XTL Biopharmaceuticals (XTLB)	Israel	$0.008B	0.00
TransCode Therapeutics (RNAZ)	United States	$0.008B	0.00
Kiora Pharmaceuticals (KPRX)	United States	$0.008B	0.00
Biomerica (BMRA)	United States	$0.008B	0.00
Heatwurx (PCSA)	United States	$0.008B	0.00
Aptorum Group (APM)	United Kingdom	$0.007B	0.00
Indaptus Therapeutics (INDP)	United States	$0.006B	0.00
Alaunos Therapeutics (TCRT)	United States	$0.006B	0.00
Redhill Biopharma (RDHL)	Israel	$0.006B	0.00
Sonoma Pharmaceuticals (SNOA)	United States	$0.006B	0.00
Decoy Therapeutics Inc (DCOY)	United States	$0.006B	0.00
Xenetic Biosciences (XBIO)	United States	$0.005B	0.00
Salarius Pharmaceuticals (SLRX)	United States	$0.005B	0.00
XORTX Therapeutics (XRTX)	Canada	$0.004B	0.00
Clearmind Medicine (CMND)	Canada	$0.004B	0.00
Lyra Therapeutics (LYRA)	United States	$0.003B	0.00
InMed Pharmaceuticals (INM)	Canada	$0.003B	0.00
Jaguar Animal Health (JAGX)	United States	$0.003B	0.00
Shuttle Pharmaceuticals Holdings (SHPH)	United States	$0.002B	0.00
Universe Pharmaceuticals INC (UPC)	China	$0.002B	0.00
CDT Equity (CDT)	United States	$0.002B	0.00
60 Degrees Pharmaceuticals (SXTP)	United States	$0.002B	0.00
PainReform (PRFX)	Israel	$0.002B	0.00
Galmed Pharmaceuticals (GLMD)	Israel	$0.001B	0.00
SciSparc (SPRC)	Israel	$0.001B	0.00
Aditxt (ADTX)	United States	$0.001B	0.00
Emisphere Technologies (EMIS)	United States	$0.000B	0.00
4D Pharma (LBPS)	United Kingdom	$0.000B	0.00
Patheon (PTHN)	Netherlands	$0.000B	0.00
RVL Pharmaceuticals (RVLP)	United States	$0.000B	0.00